Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi

Showing results (51-60 of 6,018) with videos related to

Pageof 602
Sort By:
Nursing Leadership|September 1, 1980
Primary nursing and change: a case studyC Manfredi
Frontiers in Robotics and AI|August 2, 2021
Endorobots for Colonoscopy: Design Challenges and Available TechnologiesLuigi Manfredi
Genus|January 1, 1993
[Logistic effects in the two-sex model with "harmonic mean" fertility function]P Manfredi
Recenti Progressi in Medicina|February 21, 2004
[Treatment of HIV infection in clinical practice. Wide-range genotypic resistance to all nucleoside analogues and protease inhibitors, and severe intolerance to all non-nucleoside inhibitors of inverse transcriptase]Roberto Manfredi
AIDS (London, England)|October 3, 2003
HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease managementRoberto Manfredi
Oral Diseases|October 29, 2018
Direct oral anticoagulant agents: Are they so safe?Maddalena Manfredi
The Journal of Small Animal Practice|July 18, 2019
Association between ultrasonographic appearance of urine and urinalysis in dogs and catsS Manfredi
Recenti Progressi in Medicina|December 19, 2003
[Problems in the management of HIV infection in clinical practice. Patients still on dual therapy 8 years after the introduction of HAART]Roberto Manfredi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinationsRoberto Manfredi
Recenti Progressi in Medicina|May 9, 2007
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens]Roberto Manfredi
Pageof 602

Showing results (51-60 of 6,018) with videos related to

Sort By:
Pageof 602
Nursing Leadership|September 1, 1980
Primary nursing and change: a case studyC Manfredi
Frontiers in Robotics and AI|August 2, 2021
Endorobots for Colonoscopy: Design Challenges and Available TechnologiesLuigi Manfredi
Genus|January 1, 1993
[Logistic effects in the two-sex model with "harmonic mean" fertility function]P Manfredi
Recenti Progressi in Medicina|February 21, 2004
[Treatment of HIV infection in clinical practice. Wide-range genotypic resistance to all nucleoside analogues and protease inhibitors, and severe intolerance to all non-nucleoside inhibitors of inverse transcriptase]Roberto Manfredi
AIDS (London, England)|October 3, 2003
HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease managementRoberto Manfredi
Oral Diseases|October 29, 2018
Direct oral anticoagulant agents: Are they so safe?Maddalena Manfredi
The Journal of Small Animal Practice|July 18, 2019
Association between ultrasonographic appearance of urine and urinalysis in dogs and catsS Manfredi
Recenti Progressi in Medicina|December 19, 2003
[Problems in the management of HIV infection in clinical practice. Patients still on dual therapy 8 years after the introduction of HAART]Roberto Manfredi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinationsRoberto Manfredi
Recenti Progressi in Medicina|May 9, 2007
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens]Roberto Manfredi
Pageof 602